Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by Seoul National University Hospital
Sponsor:
Collaborator:
Seoul National University Bundang Hospital
Information provided by (Responsible Party):
Ho-Seong Han, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT01111591
First received: March 31, 2009
Last updated: April 21, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Publications: